A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

NCT07066657 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors
Colorectal Cancer
Gastric Cancer
Pancreatic Cancer

Interventions

DRUG: MRG007

Sponsor

ArriVent BioPharma, Inc.

Collaborators

[object Object]